Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Unaudited Financial Results For The Quarter Ended December 31, 2020.

 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we enclose a copy of the statements containing the unaudited Financial Results of the Company for the quarter ended December 31, 2020, which has been approved at the meeting of the Board of Directors held today. We also enclose a copy of the Limited Review Report for the quarter ended December 31, 2020 issued by the Statutory Auditors. The Board Meeting commenced at 3.30 pm and concluded at 5.00 pm.
13-02-2021
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Outcome Of Meeting Of The Board Of Directors Held On February 13, 2021, Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 This is to inform you that the Board of Directors of the Company, at their meeting held today at 3.30 p.m. has, inter alia, considered and approved the un-audited financial results of the Company for the quarter ended December 31, 2020. A copy of Unaudited Financial Results and Limited Review Report as received from Statutory Auditors is enclosed for your information and record. The meeting of the Board of Directors concluded at 5.00 p.m.
13-02-2021
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended December 31, 2020.
06-02-2021
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended January 07, 2021

 Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended January 07, 2021. For more details, kindly Click here
16-01-2021
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

 Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform you that Ms. Mamta Mav, have resigned from the position of Company Secretary & Compliance Officer of the Company with effect from closing hours of January 14, 2021. The Company places on record the valuable contribution and guidance provided by Ms. Mamta Mav during her tenure as a Company Secretary & Compliance Officer of the Company. The Company is in the process of appointing a new Company Secretary and the same will be communicated to the stock exchange in due course.
14-01-2021
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mamta MavDesignation :- Company Secretary and Compliance Officer
14-01-2021
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended December 31, 2020

 Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
13-01-2021
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

 Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform you that Mr. Prahlad Bhanushali, have resigned from the position of Chief Financial Officer of the Company with effect from closing hours of January 13, 2021. The Company places on record the valuable contribution and guidance provided by Mr. Prahlad Bhanushali during his tenure as a Chief Financial Officer of the Company. The Company is in the process of appointing a new Chief Financial Officer and the same will be communicated to the stock exchanges in due course.
13-01-2021
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we are forwarding herewith a copy of the certificate dated January 07, 2021, received from Link Intime India Pvt. Ltd. the Registrar and Transfer Agent of the Company, for the quarter ended December 31, 2020.
13-01-2021
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinod Pradhan Bhanushali & PACs
11-01-2021
Next Page
Close

Let's Open Free Demat Account